Share
Susan Keefe
Quotient Therapeutics, a biotechnology company pioneering somatic genomics to advance breakthrough medicines, has appointed Susan Keefe as Chief Financial Officer.
A seasoned life sciences executive, Keefe brings three decades of experience spanning finance, accounting, and operations across the biotechnology and healthcare sectors.
Keefe most recently served as the company’s acting CFO through her role at Flagship Pioneering, the firm that founded Quotient Therapeutics. Prior to Flagship, she was Interim CFO at Benson Hill. She previously held the role of CFO at GreenLight Biosciences, where she led financial strategy for a company developing RNA-based solutions across agriculture and human health applications.
Earlier in her career, Keefe held leadership roles in finance and administration at Danforth Advisors and Aushon Biosystems. She also built foundational financial expertise through positions at SeraCare Life Sciences, Procter & Gamble, and PwC.
Keefe holds an MBA from the University of Chicago Booth School of Business and a BBA in accounting from the University of Iowa, further strengthening Quotient’s leadership team as it advances its genomics-driven therapeutic platform.
